Literature DB >> 18855015

IGF-I regulates tight-junction protein claudin-1 during differentiation of osteoblast-like MC3T3-E1 cells via a MAP-kinase pathway.

Naoko Hatakeyama1, Takashi Kojima, Kousuke Iba, Masaki Murata, Mia M Thi, David C Spray, Makoto Osanai, Hideki Chiba, Sumio Ishiai, Toshihiko Yamashita, Norimasa Sawada.   

Abstract

Insulin-like growth factor I (IGF-I) is expressed in many tissues, including bone, and acts on the proliferation and differentiation of osteoblasts as an autocrine/paracrine regulator. Tight-junction proteins have been detected in osteoblasts, and direct cell-to-cell interactions may modulate osteoblast function with respect, for example, to gap junctions. In order to investigate the regulation of expression of tight-junction molecules and of function during bone differentiation, osteoblast-like MC3T3-E1 cells and osteocyte-like MLO-Y4 cells were treated with IGF-I. In both MC3T3-E1 cells and MLO-Y4 cells, the tight-junction molecules occludin, claudin-1, -2, and -6, and the gap-junction molecule connexin 43 (Cx43) were detected by reverse transcription with polymerase chain reaction. In MC3T3-E1 cells but not MLO-Y4 cells, mRNAs of claudin-1, -2, and -6, Cx43, and type I collagen, and proteins of claudin-1 and Cx43 were increased after treatment with IGF-I. Such treatment significantly decreased paracellular permeability in MC3T3-E1 cells. The expression of claudin-1 in MC3T3-E1 cells after IGF-I treatment was mainly upregulated via a mitogen-activated protein (MAP)-kinase pathway and, in part, modulated by a PI3-kinase pathway, whereas Cx43 expression and the mediated gap-junctional intercellular communication protein did not contribute to the upregulation. Furthermore, in MC3T3-E1 cells during wound healing, upregulation of claudin-1 was observed together with an increase of IGF-I and type I collagen. These findings suggest that the induction of tight-junction protein claudin-1 and paracellular permeability during the differentiation of osteoblast-like MC3T3-E1 cells after treatment with IGF-I is regulated via a MAP-kinase pathway, but not with respect to gap junctions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855015      PMCID: PMC2692508          DOI: 10.1007/s00441-008-0690-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  58 in total

Review 1.  Buried alive: how osteoblasts become osteocytes.

Authors:  Tamara A Franz-Odendaal; Brian K Hall; P Eckhard Witten
Journal:  Dev Dyn       Date:  2006-01       Impact factor: 3.780

Review 2.  Cell-cell interactions in regulating osteogenesis and osteoblast function.

Authors:  Joseph P Stains; Roberto Civitelli
Journal:  Birth Defects Res C Embryo Today       Date:  2005-03

Review 3.  Role of connexin genes in growth control.

Authors:  H Yamasaki; C C Naus
Journal:  Carcinogenesis       Date:  1996-06       Impact factor: 4.944

4.  Patients with Laron syndrome have Osteopenia/Osteoporosis.

Authors:  Z Laron; B Klinger; A Silbergeld
Journal:  J Bone Miner Res       Date:  1999-01       Impact factor: 6.741

5.  Isolated primary osteocytes express functional gap junctions in vitro.

Authors:  Guoliang Gu; Martin Nars; Teuvo A Hentunen; Kalervo Metsikkö; H Kalervo Väänänen
Journal:  Cell Tissue Res       Date:  2005-09-21       Impact factor: 5.249

6.  ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells.

Authors:  W Zhang; J C Lee; S Kumar; M Gowen
Journal:  J Bone Miner Res       Date:  1999-04       Impact factor: 6.741

7.  Possible involvement of phosphatidylinositol 3-kinase/Akt pathway in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblasts.

Authors:  T Noda; H Tokuda; M Yoshida; E Yasuda; Y Hanai; S Takai; O Kozawa
Journal:  Horm Metab Res       Date:  2005-05       Impact factor: 2.936

8.  Acute activation of Erk1/Erk2 and protein kinase B/akt proceed by independent pathways in multiple cell types.

Authors:  Doris Chiu; Kewei Ma; Alexander Scott; Vincent Duronio
Journal:  FEBS J       Date:  2005-09       Impact factor: 5.542

9.  Modulation of connexin43 alters expression of osteoblastic differentiation markers.

Authors:  Zhongyong Li; Zhiyi Zhou; Marnie M Saunders; Henry J Donahue
Journal:  Am J Physiol Cell Physiol       Date:  2005-11-30       Impact factor: 4.249

10.  Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells.

Authors:  Junichi Ikenouchi; Mikio Furuse; Kyoko Furuse; Hiroyuki Sasaki; Sachiko Tsukita; Shoichiro Tsukita
Journal:  J Cell Biol       Date:  2005-12-19       Impact factor: 10.539

View more
  20 in total

Review 1.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

Review 2.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

Review 3.  New insights into mineralogenic effects of vanadate.

Authors:  Vincent Laizé; Daniel M Tiago; Manuel Aureliano; M Leonor Cancela
Journal:  Cell Mol Life Sci       Date:  2009-09-04       Impact factor: 9.261

4.  Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing.

Authors:  Pierre O Bagnaninchi; Nicola Drummond
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

5.  Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.

Authors:  Harry C Blair; Quitterie C Larrouture; Yanan Li; Hang Lin; Donna Beer-Stoltz; Li Liu; Rocky S Tuan; Lisa J Robinson; Paul H Schlesinger; Deborah J Nelson
Journal:  Tissue Eng Part B Rev       Date:  2016-12-27       Impact factor: 6.389

Review 6.  Emerging multifunctional roles of Claudin tight junction proteins in bone.

Authors:  Fatima Z Alshbool; Subburaman Mohan
Journal:  Endocrinology       Date:  2014-04-23       Impact factor: 4.736

7.  Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation.

Authors:  Gabriel R Linares; Robert Brommage; David R Powell; Weirong Xing; Shin-Tai Chen; Fatima Z Alshbool; K-H William Lau; Jon E Wergedal; Subburaman Mohan
Journal:  J Bone Miner Res       Date:  2012-07       Impact factor: 6.741

Review 8.  Cellular and extracellular matrix of bone, with principles of synthesis and dependency of mineral deposition on cell membrane transport.

Authors:  Paul H Schlesinger; Harry C Blair; Donna Beer Stolz; Vladimir Riazanski; Evan C Ray; Irina L Tourkova; Deborah J Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2019-09-18       Impact factor: 4.249

9.  Disruption of claudin-18 diminishes ovariectomy-induced bone loss in mice.

Authors:  Ha-Young Kim; Catrina Alarcon; Sheila Pourteymour; Jon E Wergedal; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-08       Impact factor: 4.310

10.  Lost miRNA surveillance of Notch, IGFR pathway--road to sarcomagenesis.

Authors:  K Galoian; T Guettouche; B Issac; L Navarro; H T Temple
Journal:  Tumour Biol       Date:  2014-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.